Laplace Interventional Inc. Announces first close of an Oversubscribed Series B Financing of $12.9M for its Transcatheter Tricuspid Valve Technology
/PRNewswire/ -- Minnesota based Laplace Interventional, a medical device company developing a transcatheter tricuspid valve technology, announced today that it...
Source: prnewswire.com